Vinblastine sulfate and Metastases to bone - a phase IV clinical study of FDA data

Summary:

Metastases to bone is reported as a side effect among people who take Vinblastine sulfate (vinblastine sulfate), especially for people who are male, 50-59 old, have been taking the drug for 1 - 6 months also take Zometa, and have Bone disorder.

The phase IV clinical study analyzes which people have Metastases to bone when taking Vinblastine sulfate. It is created by eHealthMe based on reports of 2,781 people who have side effects when taking Vinblastine sulfate from the FDA, and is updated regularly.

What is Vinblastine sulfate?

Vinblastine sulfate has active ingredients of vinblastine sulfate. eHealthMe is studying from 2,788 Vinblastine sulfate users. Check the latest studies of Vinblastine sulfate.

What is Metastases to bone?

Metastases to bone (cancer spreads to bone) is found to be associated with 1,127 drugs and 902 conditions by eHealthMe. Check the latest studies of Metastases to bone.

On Jul, 17, 2026

2,781 people reported to have side effects when taking Vinblastine sulfate.
Among them, 17 people (0.61%) have Metastases to bone.

Could Vinblastine sulfate cause Metastases to bone?

Among these 17 people:

How long have people been on Vinblastine sulfate when they have Metastases to bone? *

What is the gender of people who have Metastases to bone when taking Vinblastine sulfate? *

female: 5.88 %
male: 94.12 %

What is the age of people who have Metastases to bone when taking Vinblastine sulfate? *

What are other drugs people take besides Vinblastine sulfate? *

What are other side effects people have besides Metastases to bone? *

Thrombocytopenia (decrease of platelets in blood): 10 people, 58.82%
Joint Pain: 10 people, 58.82%
Metastases To Lung (cancer spreads to lung): 9 people, 52.94%
Back Pain: 9 people, 52.94%
Fall: 9 people, 52.94%
Anaemia (lack of blood): 8 people, 47.06%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 8 people, 47.06%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 7 people, 41.18%
Deformity (disfigurement): 7 people, 41.18%
Pneumonia: 7 people, 41.18%

What are the existing conditions these people have? *

Bone Disorder: 6 people, 35.29%
Renal Cell Carcinoma Stage Unspecified (kidney cancer in unknown stage): 1 person, 5.88%
Renal Cell Carcinoma (a kidney cancer): 1 person, 5.88%
Hodgkin's Lymphoma (cancer originating from white blood cells): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Vinblastine sulfate and have Metastases to bone?

- Check whether Metastases to bone is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vinblastine sulfate:

Vinblastine sulfate (2,788 reports)

Browse all side effects of Vinblastine sulfate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Metastases to bone:

Metastases to bone (1,127 drugs)

Browse all the conditions that are associated with Metastases to bone:

Metastases to bone (902 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on vinblastine sulfate (the active ingredients of Vinblastine sulfate) and Vinblastine sulfate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.